EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Anti-Inflammatory Effects of Zingiber officinale Ethanolic Extract on Immune Biomarkers (Anti-CCP, RF, IL-6, TNF-α) and Hematological Parameters in a Collagen-Induced Arthritis Rat Model

Basher Boughdady

Pharaonic Journal of Science · 2026-11-05 · 2 (4) · 8-19

DOI: 10.71428/pjs.2026.0402 ↗
AbstractBibliografische Angaben

Abstract

Background: Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease characterized by progressive joint destruction driven by autoimmune and cytokine-mediated inflammatory pathways. Zingiber officinale (ginger) contains bioactive phenolic compounds, principally 6-gingerol and 6-shogaol, that inhibit COX-2, LOX, and NF-κB, thereby reducing cytokine production. Although ginger reduces TNF-α and IL-6 in adjuvant arthritis models, this study examines its effects in the CIA model alongside immune biomarkers and hematological inflammatory indices. Objective: To evaluate the multi-domain anti-inflammatory effects of Z. officinale ethanolic extract (ZOE) at 250 mg/kg/day in the CIA Wistar rat model vs. methotrexate (MTX) as a positive comparator. Methods: Sixty adult male Wistar albino rats were randomized into four groups (n=15 each): G1 control; G2 CIA+vehicle; G3 CIA+ZOE (250 mg/kg/day, Days 28–56); G4 CIA+MTX (0.3 mg/kg/week i.p.). All five biomarker domains were assessed at Day 56 sacrifice: immune (Anti-CCP, RF, hs-CRP, IL-6, and TNF-α); lipid profile with AIP; HOMA-IR; oxidative stress (MDA, SOD, GSH, and NO); and CBC-derived inflammatory indices (NLR, PLR, SII, and MPV). Results: CIA was confirmed in 100% of treated animals. Anti-CCP declined 54.7% (84.8→38.4 U/mL); IL-6 −59.0%; TNF-α −57.9%; hs-CRP fell below the 3.0 mg/L cardiovascular risk threshold. AIP declined from 0.318 to 0.164 (below the 0.21 high-risk threshold). SII declined by 56.1%. Key correlation: AIP vs. hs-CRP r=+0.794 (p0.05); combined with a superior safety profile, these findings support ginger's role as a complementary therapeutic agent in RA management.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →